Despite insufficient evidence to support direct-to-consumer genetic testing in routine clinical care, cardiovascular ...

The best is yet to come, however, for genetic testing in cardiac disease. The greatest promise and power of genetic testing lies in the future as research continues to unravel the molecular basis ...

Genetic testing resulted in diagnostic refinement with a potential change in clinical management in 8% of probands, according ...

A pioneering screening trial, recently announced at the Bethesda Lyceum, aims to transform community health by providing ...

Sara Adair’s life was saved by an iPhone ultrasound probe after suffering an aortic dissection. Quick diagnosis allowed for ...

Scientists at the Icahn School of Medicine at Mount Sinai have uncovered new genetic interactions that may contribute to congenital heart disease (CHD), one of the most common birth defects worldwide.

The cardiac biomarkers market is primarily driven by several factors, including the increasing prevalence of cardiovascular ...

Genetic testing resulted in diagnostic refinement with a potential change in clinical management in 8% of probands, according to Rafik Tadros, MD, PhD, of Montreal Heart Institute, and colleagues.